Nanhua Bio Operating Margin vs. Book Value Per Share
| 000504 Stock | 10.42 0.08 0.76% |
For Nanhua Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nanhua Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nanhua Bio Medicine utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nanhua Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nanhua Bio Medicine over time as well as its relative position and ranking within its peers.
Nanhua |
Nanhua Bio Medicine Book Value Per Share vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nanhua Bio's current stock value. Our valuation model uses many indicators to compare Nanhua Bio value to that of its competitors to determine the firm's financial worth. Nanhua Bio Medicine is number one stock in operating margin category among its peers. It is rated fourth in book value per share category among its peers creating about 63.81 of Book Value Per Share per Operating Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanhua Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanhua Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanhua Book Value Per Share vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Nanhua Bio |
| = | 0.01 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Nanhua Bio |
| = | 0.75 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Nanhua Book Value Per Share Comparison
Nanhua Bio is currently under evaluation in book value per share category among its peers.
Nanhua Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nanhua Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nanhua Bio will eventually generate negative long term returns. The profitability progress is the general direction of Nanhua Bio's change in net profit over the period of time. It can combine multiple indicators of Nanhua Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Income Before Tax | -44.7 M | -42.5 M | |
| Net Loss | -11.4 M | -10.9 M | |
| Net Loss | -28.2 M | -26.8 M | |
| Income Tax Expense | 9.4 M | 9.9 M | |
| Operating Income | -9.1 M | -8.6 M | |
| Net Interest Income | -9.1 M | -9.6 M | |
| Interest Income | 2.3 M | 2.5 M | |
| Net Loss | -46.8 M | -44.4 M | |
| Change To Netincome | 25.5 M | 26.8 M |
Nanhua Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nanhua Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nanhua Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nanhua Bio's important profitability drivers and their relationship over time.
Use Nanhua Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nanhua Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanhua Bio will appreciate offsetting losses from the drop in the long position's value.Nanhua Bio Pair Trading
Nanhua Bio Medicine Pair Trading Analysis
The ability to find closely correlated positions to Nanhua Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nanhua Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nanhua Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nanhua Bio Medicine to buy it.
The correlation of Nanhua Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nanhua Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nanhua Bio Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nanhua Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nanhua Bio position
In addition to having Nanhua Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Russia On Wall Street Thematic Idea Now
Russia On Wall Street
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Nanhua Stock
To fully project Nanhua Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nanhua Bio Medicine at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nanhua Bio's income statement, its balance sheet, and the statement of cash flows.